(-)-Emtricitabine triphosphate sodium salt
CAS: 145819-92-7
Ref. 3D-NE182496
| 1mg | 1.414,00 € | ||
| 2mg | 2.357,00 € | ||
| 5mg | 3.927,00 € | ||
| 250µg | 526,00 € | ||
| 500µg | 835,00 € |
Información del producto
- Triphosphoric acid P-[[(2R,5S)-5-(4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolan-2-yl]methyl] ester sodiumTriphosphoric a cid (2R-cis)-P-[[5-(4-amino-5- fluoro-2-oxo-1(2H)-pyrimidinyl)-1,3-oxathiolan-2-yl]methyl] ester sodium
- 5-Fluoro-1-(2-Hydroxymethyl)-1,3-Oxathiolane-5-Yl-Cytidine-5'-Triphosphate
- [(2R,5S)-5-(4-amino-5-fluoro-2,6-dioxo-3H-pyrimidin-1-yl)-1,3-oxathiolan-2-yl]methyl-(hydroxy-phosphonooxy-phosphoryl)oxy-phosphinic acid
(-)-Emtricitabine triphosphate sodium salt is a novel antiviral drug that is used to treat HIV/AIDS. It is a deoxyribonucleoside analog of cytidine and is structurally related to lamivudine. It inhibits the synthesis of viral DNA by competitively inhibiting the activity of reverse transcriptase, an enzyme required for this process. Emtricitabine triphosphate sodium salt has been shown to be active against HIV-1, HIV-2, and other strains of human immunodeficiency virus (HIV) in laboratory studies. The drug does not appear to have any effect on normal cells because it does not cross the cell membrane.
Efforts are under way to develop an orally bioavailable form of emtricitabine triphosphate sodium salt as well as new prodrugs with improved properties.
Propiedades químicas
Consulta técnica sobre: 3D-NE182496 (-)-Emtricitabine triphosphate sodium salt
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
